The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCEMP.
BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/
To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.
The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.
In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.
The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.
Target Audience: These Literature Studies are designed to help board-certified pharmacists who are seeking recertification contact hours to maintain their Board of Pharmacy Specialties (BPS).
Emergency Medicine Specialty Recertification Literature Study Module 1A: Infectious DiseasesActivity Number: 0204-9999-26-932-H01-P
Contact Hour(s): 3.00
Activity Type: Application BasedLearning Objectives
- Learning Objectives:
- Describe the 2025 clinical practice guideline from the Infectious Diseases Society of America (IDSA) on management and treatment of complicated urinary tract infection
- Develop recommendations for the treatment of patients with complicated urinary tract infection (UTI)
Koehl J, Spolsdoff D, Negaard B, Lewis A, Santiago R, Krenz J, Polotti A, Feldman R, Slocum G, Zimmerman D, Howington GT, Sarangarm P, Mattson AE, Brown C, Zepeski A, Rech MA, Faine B. Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study. Ann Emerg Med. 2025 Mar;85(3):240-248. doi: 10.1016/j.annemergmed.2024.10.013. Epub 2024 Nov 20. PMID: 39570254.
- Learning Objectives:
- Describe the COPY-ED study by Koehl and colleagues comparing the use of oral cephalosporins with fluroquinolones or trimethoprim/sulfamethoxazole (TMP-SMX) for treatment of pyelonephritis after discharge home from the emergency department
- Develop recommendations for the prescribing of empiric antibiotic therapy in the emergency department (ED) for outpatient use to treat pyelonephritis at home
Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-partner treatment to prevent recurrence of bacterial vaginosis. N Engl J Med 2025; 392: 947 - 957.
- Learning Objectives:
- Describe the StepUp study by Vodstrcil and colleagues of the impact of male partner treatment on the recurrence of bacterial vaginosis
- Develop recommendations for the treatment of bacterial vaginosis to minimize the risk of recurrence
Draper HM, Rybak MJ, LaPlante KL, Lodise T, Sakoulas G, Burk M, Cunningham FE. Antibiotic stewardship in the emergency department setting: focus on oral antibiotic selection for adults with skin and soft tissue infections. Am J Health-Syst Pharm. 2024;81(21):e677-e683. doi: 10.1093/ajhp/zxae163. PMID: 38965915; PMCID: PMC11497082.
- Learning Objectives:
- Describe the special feature article by Draper and colleagues about an expert advisory panel’s suggested strategies for antibiotic stewardship in the treatment of skin and soft tissue infections (SSTIs), with a focus on oral antibiotic use in the emergency department (ED) setting for adults who will be treated as outpatients.
- Develop recommendations for antibiotic stewardship in the use of oral antibiotics for the treatment of skin and soft tissue infections (SSTIs) in the emergency department (ED) setting for adults who will be treated as outpatients
|
Emergency Medicine Specialty Recertification Literature Study Module 1B: PediatricsActivity Number: 0204-9999-26-933-H01-P
Contact Hour(s): 4.00
Activity Type: Application BasedLearning Objectives
Lasa JJ, Dhillon GS, Duff JP, et al. Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2025; 152 (suppl 2): S479 – S537.
- Learning Objectives:
- Describe the 2025 American Heart Association (AHA) and American Academy of Pediatrics (AAP) pediatric advanced life support (PALS) guidelines for cardiopulmonary resuscitation and emergency cardiovascular care pertaining to drug administration during cardiac arrest; post-cardiac arrest care, treatment, and monitoring; management of shock; atropine use for emergency intubation; treatment of tachyarrhythmias; and management of pulmonary hypertension, including treatment of infants and children with pulmonary hypertensive crises
- Develop recommendations for drug administration during cardiac arrest; post-cardiac arrest care, treatment, and monitoring; management of shock; atropine use for emergency intubation; treatment of tachyarrhythmias; and management of pulmonary hypertension in pediatric patients
Tilley H, Enderby A, VanWert E, Choi S. Trends in pediatric emergency medicine: focus on behavioral health, substance use, and safety. Am J Health-Syst Pharm. 2025;, zxaf127, https://doi.org/10.1093/ajhp/zxaf127
- Learning Objectives:
- Describe recent trends in medication errors, behavioral health emergencies, and substance use involving children and adolescents within and outside the emergency department and approaches to optimizing pharmacotherapeutic care for this high-risk patient population
- Develop recommendations to improve the level of pediatric readiness in the emergency department and provide pharmacotherapeutic care for children and adolescents with behavioral health emergencies or substance use
Mills KP, Kemper M, Charatcharungkiat N, Hoganson GM. Pharmacotherapy considerations for pediatric acute agitation management in the emergency department. Am J Health Syst Pharm. 2024;81(23):e727-e741
- Learning Objectives:
- Describe the risk factors for acute agitation and the efficacy and safety of pharmacotherapies for its management in pediatric patients in the emergency department based on available literature
- Develop recommendations for the management of acute agitation in pediatric patients in the emergency department
Gwarzo I, Coleman KD, McKinley K, et al. Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain. JAMA Pediatr. Published online September 02, 2025. doi:10.1001/jamapediatrics.2025.2967
- Learning Objectives:
- Describe the study by Gwarzo and colleagues of the relationship between the timing of administration of opioids to pediatric patients with acute sickle cell disease (SCD) pain in the emergency department and hospital admissions for SCD pain
- Develop recommendations for the timing of administration of opioids to pediatric patients with acute uncomplicated sickle cell disease (SCD) pain in the emergency department
Del Pizzo J; Fein JA, MPH. Oral Ketamine and Midazolam for Procedural Sedation in the Pediatric Emergency Department: A Retrospective Study. Pediatric Emergency Care 41(2):p 122-126, February 2025. DOI: 10.1097/PEC.0000000000003291
- Learning Objectives:
- Describe the study by Del Pizzo and Fein of oral ketamine and midazolam for procedural sedation in pediatric patients in the emergency department
- Develop recommendations for the use of needle-free procedural sedation in pediatric patients in the emergency department
Freedman SB, Williamson-Urquhart S, Plint AC, et al. Multidose ondasetron after emergency visits in children with gastroenteritis. N Engl J Med 2025; 393: 255 - 266.
- Learning Objectives:
- Describe the study by Freedman and colleagues of postdischarge use of ondansetron in pediatric patients with acute gastroenteritis-associated vomiting who are treated in the emergency department
- Develop recommendations for provision of ondansetron at the time of discharge from the emergency department to pediatric patients with acute gastroenteritis-associated vomiting
|
Emergency Medicine Specialty Recertification Literature Study Module 1C: CardiologyActivity Number: 0204-9999-26-934-H01-P
Contact Hour(s): 3.00
Activity Type: Application BasedLearning Objectives
Hyland SJ, Eaton RE, Max ME, Egbert SB, Wong SA, Blais DM. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist's role, part 1: Patient presentation through revascularization. Am J Health Syst Pharm. 2025 Jun 26;82(13):e578-e595. doi: 10.1093/ajhp/zxae303. PMID: 39450757.
- Learning Objectives:
- Describe the key pharmacotherapeutic modalities and considerations for patients with acute ST-elevation myocardial infarction (STEMI) and the pharmacist’s role in the critical initial phases of care
- Develop recommendations for patients with ST-elevation myocardial infarction (STEMI) during the critical initial phases of care between the time of patient presentation and revascularization
Krug N, Baize P, Barre S, Barnes R, Weigartz K. Comparison of initial adenosine dose conversion rate for supraventricular tachycardia in the emergency department. Am J Emerg Med 2024; 85: 117 - 122
- Learning Objectives:
- Describe the study by Krug and colleagues of adenosine in patients with supraventricular tachycardia (SVT) presenting to the emergency department (ED)
- Develop recommendations for the use of adenosine in patients with supraventricular tachycardia (SVT) presenting to the emergency department (ED)
Wigginton JG, Agarwal S, Bartos JA, et al. Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2025; 152 (Suppl 2): S538 - 577.
- Learning Objectives:
- Describe the 2025 American Heart Association (AHA) adult advanced life support guidelines for cardiopulmonary resuscitation and emergency cardiovascular care pertaining to the use of vasopressor and nonvasopressor medications in adults in cardiac arrest, management of adults with tachycardia, and treatment of adults with atrial fibrillation or flutter and rapid ventricular response
- Develop recommendations for the use of vasopressor and nonvasopressor medications in adults in cardiac arrest, management of adults with tachycardia, and treatment of adults with atrial fibrillation or flutter and rapid ventricular response
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.